Skip to Content
Merck
  • How do cryptogenic and symptomatic infantile spasms differ? Review of biochemical studies in Finnish patients.

How do cryptogenic and symptomatic infantile spasms differ? Review of biochemical studies in Finnish patients.

Journal of child neurology (1996-09-01)
R S Riikonen
ABSTRACT

Infants with cryptogenic infantile spasms seem to differ from those with symptomatic spasms in having a higher cerebrospinal fluid corticotropin content, different levels of corticotropin release after exogenous vasopressin, higher serum levels of progesterone, higher dehydroepiandrosterone: androstenedione ratio (during corticotropin therapy), a higher cerebrospinal fluid gamma-aminobutyric acid content, and higher cerebrospinal fluid nerve growth factor concentrations. It remains to be seen whether the biochemical differences between the two groups are specific or only happen to correlate with the early brain damage. However, these differences would explain many pathophysiologic features of infantile spasms.

MATERIALS
Product Number
Brand
Product Description

Supelco
Androstenedione solution, 1.0 mg/mL in acetonitrile, ampule of 1 mL, certified reference material, Cerilliant®
Supelco
4-Androstene-3,17-dione, VETRANAL®, analytical standard